Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Dipenkumar Modi"'
Autor:
Muhit Ozcan, Yuqin Song, Seung Tae Lee, Felix Mensah, Dipenkumar Modi, Alexander Fossa, Won Seog Kim, Ewa Paszkiewicz-Kozik, Yazeed Sawalha, Omur Gokmen Sevindik, Lalita Norasetthada, Armando Santoro, Kumudu Pathiraja, Samhita Chakraborty, Patricia Marinello, David Lavie
Publikováno v:
HemaSphere, Vol 7, p e03345ef (2023)
Externí odkaz:
https://doaj.org/article/5aca785fd435480da499be81ff0b9ce3
Autor:
Charlotte B. Wagner, Ken Boucher, Adrienne Nedved, Ivana N. Micallef, Sanjal Desai, Haris Hatic, Gaurav Goyal, Erin Zacholski, Amanda Fegley, Audrey M. Sigmund, David A. Bond, Courtney Samuels, Manali K. Kamdar, Sheeba Ba Aqeel, Pallawi Torka, Kira MacDougall, Azra Borogovac, Sridevi Rajeeve, Suchitra Sundaram, Kalub Fedak, Dipenkumar Modi, Elizabeth Travers, Sabarish Ayyappan, Nitin Chilakamarri, Elizabeth A. Brem, Daniel A. Ermann, Lindsey A. Fitzgerald, Boyu Hu, Deborah M. Stephens, Harsh Shah
Publikováno v:
Haematologica, Vol 108, Iss 11 (2023)
Sixteen cycles of Brentuximab vedotin (BV) after autologous stem cell transplant (ASCT) in high-risk relapsed/refractory classical Hodgkin lymphoma demonstrated an improved 2-year progression-free survival (PFS) over placebo. However, most patients a
Externí odkaz:
https://doaj.org/article/551d8a1644b244c18b60306f73172409
Autor:
Harsh Shah, Victoria Vardell, Erin Zacholski, Amanda Fegley, Kalub Fedak, Suchitra Sundaram, Sridevi Rajeeve, Gaurav Goyal, Haris Hatic, Pallawi Torka, Sheeba Ba Aqeel, Azra Borogovac, Kira Macdougall, Shalin Kothari, Anna Kress, Dipenkumar Modi, Elizabeth Travers, Nitin Chilakamarri, Elizabeth Brem, Deborah M. Stephens, Boyu Hu, Lindsey Fitzgerlad, Charlotte Wagner, Daniel Ermann
Publikováno v:
HemaSphere, Vol 6, Pp 47-48 (2022)
Externí odkaz:
https://doaj.org/article/12d2af81c3be476aa4cbc5e716cec24c
Autor:
Dipenkumar Modi, Samer Alkassis, Seongho Kim, Andrew Kin, Abhinav Deol, Lois Ayash, Voravit Ratanatharathorn, Joseph P. Uberti
Publikováno v:
Leukemia & Lymphoma. :1-10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c431ccf3fef246b98741b2824cd9e78f
https://doi.org/10.1080/10428194.2023.2206181
https://doi.org/10.1080/10428194.2023.2206181
Autor:
Michael Boyiadzis, Mei-Jie Zhang, Karen Chen, Hisham Abdel-Azim, Muhammad Bilal Abid, Mahmoud Aljurf, Ulrike Bacher, Talha Badar, Sherif M. Badawy, Minoo Battiwalla, Nelli Bejanyan, Vijaya Raj Bhatt, Valerie I. Brown, Paul Castillo, Jan Cerny, Edward A. Copelan, Charles Craddock, Bhagirathbhai Dholaria, Miguel Angel Diaz Perez, Christen L. Ebens, Robert Peter Gale, Siddhartha Ganguly, Lohith Gowda, Michael R. Grunwald, Shahrukh Hashmi, Gerhard C. Hildebrandt, Madiha Iqbal, Omer Jamy, Mohamed A. Kharfan-Dabaja, Nandita Khera, Hillard M. Lazarus, Richard Lin, Dipenkumar Modi, Sunita Nathan, Taiga Nishihori, Sagar S. Patel, Attaphol Pawarode, Wael Saber, Akshay Sharma, Melhem Solh, John L. Wagner, Trent Wang, Kirsten M. Williams, Lena E. Winestone, Baldeep Wirk, Amer Zeidan, Christopher S. Hourigan, Mark Litzow, Partow Kebriaei, Marcos de Lima, Kristin Page, Daniel J. Weisdorf
Publikováno v:
Leukemia. 37:1006-1017
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4ab9255934538c49be1ef1121fe5be4
https://doi.org/10.1038/s41375-022-01738-3
https://doi.org/10.1038/s41375-022-01738-3
Autor:
Charlotte B. Wagner, Ken Boucher, Adrienne Nedved, Ivana N Micallef, Sanjal Desai, Haris Hatic, Gaurav Goyal, Erin Zacholski, Amanda Fegley, Audrey M. Sigmund, David A. Bond, Courtney Samuels, Manali K. Kamdar, Sheeba Ba Aqeel, Pallawi Torka, Kira MacDougall, Azra Borogovac, Sridevi Rajeeve, Suchitra Sundaram, Kalub Fedak, Dipenkumar Modi, Elizabeth Travers, Sabarish Ayyappan, Nitin Chilakamarri, Elizabeth A. Brem, Daniel A. Ermann, Lindsey A. Fitzgerald, Boyu Hu, Deborah M. Stephens, Harsh Shah
Publikováno v:
Haematologica.
Sixteen cycles of Brentuximab vedotin (BV) after autologous stem cell transplant (ASCT) in high-risk relapsed/refractory classical Hodgkin lymphoma (r/r cHL) demonstrated an improved 2-year progression free survival (PFS) over placebo. However, most
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1b273bb1764670f7bc98462ac2828c0
https://doi.org/10.3324/haematol.2023.282780
https://doi.org/10.3324/haematol.2023.282780
Autor:
Muthu Veeraputhiran, Amitkumar Mehta, Alvaro J. Alencar, Dipenkumar Modi, Timothy J. Voorhees, Mayur Narkhede
Publikováno v:
Blood. 140:12089-12091
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ccdd5effcab71cea5a4ef514f1a73a20
https://doi.org/10.1182/blood-2022-158595
https://doi.org/10.1182/blood-2022-158595
Autor:
Charlotte B Wagner, Daniel A. Ermann, Ken Boucher, Adrienne N. Nedved, Ivana N. Micallef, Sanjal H Desai, Haris Hatic, Gaurav Goyal, Erin Zacholski, Amanda Fegley, Audrey M. Sigmund, David A. Bond, Courtney Samuels, Manali K. Kamdar, Sheeba Ba Aqeel, Pallawi Torka, Kira MacDougall, Azra Borogovac, Sridevi Rajeeve, Suchitra Sundaram, Kalub Fedak, Dipenkumar Modi, Elizabeth Travers, Sabarish Ayyappan, Nitin Chilakamarri, Elizabeth A Brem, Deborah M. Stephens, Boyu Hu, Lindsey A. Fitzgerald, Harsh Shah
Publikováno v:
Blood. 140:9390-9392
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9183e175d61383087cc39964b248cd2
https://doi.org/10.1182/blood-2022-159001
https://doi.org/10.1182/blood-2022-159001
Autor:
Vijaya Raj Bhatt, Stephanie J. Lee, Jaime M. Preussler, Gerhard C. Hildebrandt, Tao Wang, Monzr M. Al Malki, Amer Beitinjaneh, Dipenkumar Modi, Margaret L. MacMillan, Lazaros J. Lekakis, Sherif M. Badawy, Akshay Sharma, Siddhartha Ganguly, Carrie L. Kitko, Hemant S. Murthy, Richard T. Maziarz, Stephen R. Spellman, Karen Chen, Mukta Arora, Betty K. Hamilton, Joseph A. Pidala, Hongtao Liu
Publikováno v:
Transplantation and Cellular Therapy. 28:34-42
The effect of chronic graft-versus-host disease (cGVHD) on the risk of nonrelapse mortality (NRM) and relapse has not been specifically studied in older adults, who are increasingly undergoing allogeneic hematopoietic cell transplantation (alloHCT) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07b7cfe24d5c9b1b6bd8b982847e8141
https://doi.org/10.1016/j.jtct.2021.10.002
https://doi.org/10.1016/j.jtct.2021.10.002
Publikováno v:
Leukemia & Lymphoma. 63:855-864
T-cell lymphoma (TCL) poses a therapeutic challenge. Allogeneic stem cell transplant (alloSCT) is frequently offered in primary refractory disease or failed autologous transplant. We systematically searched published articles on outcomes of alloSCT i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50c1870d10a50d2aae38c97992f0253a
https://doi.org/10.1080/10428194.2021.1999438
https://doi.org/10.1080/10428194.2021.1999438